Proteomic-Based Approach for the Identification of Tumor Markers Associated with Hepatocellular Carcinoma
Authors:
Open Access
- 1 January 2001
- journal article
- research article
- Published by Hindawi Limited in Disease Markers
- Vol. 17 (4) , 217-223
Abstract
There is increasing evidence for an immune response to cancer in humans, demonstrated in part by the identification of autoantibodies to tumor antigens. The identification of panels of tumor antigens that elicit a humoral response may have utility in cancer screening, diagnosis or in establishing prognosis. Several approaches are currently available for the identification of tumor antigens. We have used a proteomic-based approach for the identification of tumor antigens that induce an antibody response which we have applied to hepatocellular carcinoma, a major type of cancer worldwide. Two-dimensional gel electrophoresis allows simultaneous separation of several thousand individual proteins from tumor tissue or tumor cell lines. Proteins eliciting a humoral response in HCC were identified by 2-D Western blotting using sera from patients with hepatocellular carcinoma, followed by mass spectrometry analysis and database search. The common occurrence of autoantibodies to specific proteins may have utility for HCC screening and diagnosis.Keywords
This publication has 42 references indexed in Scilit:
- Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinomaClinica Chimica Acta, 2000
- Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombusJournal of Cancer Research and Clinical Oncology, 2000
- Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinomaJournal of Gastroenterology, 1998
- Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patientsCancer, 1998
- Human tumor antigens recognized by T-cellsImmunologic Research, 1997
- The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombinLiver Transplantation and Surgery, 1995
- Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinomaGlycoconjugate Journal, 1995
- A Cell-Cycle Nuclear Autoantigen Containing Wd-40 Motifs Expressed Mainly in S and G2-Phase CellsBiochemical and Biophysical Research Communications, 1995
- Des-γ-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical reviewHepatology, 1993
- A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosisHepatology, 1993